Transmarket Holdings’s Avidity Biosciences RNAM Stock Holding History

Transmarket Holdings’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,537	Closed	-$1.41M	–	55
2025 Q4	$1.41M	Buy	+19,537	New	+$1.26M	1.03%	18

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Transmarket Holdings's RNAM Position: Q1 2026 in Review

Transmarket Holdings sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 19,537 shares — an estimated $1.41M sold.

Transmarket Holdings first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $1.41M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Transmarket Holdings reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Transmarket Holdings sold 19,537 Avidity Biosciences shares in Q1 2026, an estimated $1.41M.
Transmarket Holdings first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Transmarket Holdings's Avidity Biosciences position peaked at $1.41M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Transmarket Holdings's 13F filing for Q1 2026, filed 13 May 2026.